Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,916,629
-
Total 13F shares
-
14,735,208
-
Share change
-
-1,994,785
-
Total reported value
-
$9,335,513
-
Price per share
-
$0.63
-
Number of holders
-
49
-
Value change
-
-$2,241,745
-
Number of buys
-
21
-
Number of sells
-
30
Institutional Holders of Werewolf Therapeutics, Inc. - Common Stock (HOWL) as of Q4 2025
As of 31 Dec 2025,
Werewolf Therapeutics, Inc. - Common Stock (HOWL) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,735,208 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., VANGUARD GROUP INC, MPM BIOIMPACT LLC, BANK OF AMERICA CORP /DE/, RENAISSANCE TECHNOLOGIES LLC, Lynx1 Capital Management LP, SPHERA FUNDS MANAGEMENT LTD., DC Funds, LP, GEODE CAPITAL MANAGEMENT, LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.